Evidence map›Paper›PMID 38336793›Full record

ArticleTrials2024

Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania.

Jillian L Kadota, Laura J Packel, Matilda Mlowe, Nzovu Ulenga, Natalino Mwenda, Prosper F Njau, William H Dow, Jingshen Wang, Amon Sabasaba, Sandra I McCoy

2 registry-linked trialsAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05248100 nacompletednot on this map

Strengthening the Continuity of HIV Care in Tanzania With Economic Support: Phase I

TypeinterventionalSponsorUniversity of California, BerkeleyRan2022 to 2024Enrolled567ConditionsHIV (Human Immunodeficiency Virus)ArmsConditional Cash Transfer
NCT05373095 nacompletednot on this map

Strengthening the Continuity of HIV Care in Tanzania With Economic Support: Phase II

TypeinterventionalSponsorUniversity of California, BerkeleyRan2023 to 2026Enrolled692ConditionsHIV (Human Immunodeficiency Virus)ArmsPKC (adapted adherence counseling) and Conditional Cash Transfers
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jillian L Kadota *Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA. jill.kadota@berkeley.edu.ORCID http://orcid.org/0000-0003-4568-8681
Laura J Packel *Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.
Matilda MloweHealth for a Prosperous Nation, Dar Es Salaam, Tanzania.
Nzovu UlengaManagement and Development for Health, Dar Es Salaam, Tanzania.
Natalino Mwenda, Rasello, Dar Es Salaam, Tanzania.
Prosper F NjauMinistry of Health, Dodoma, Tanzania.
William H DowDivision of Health Policy and Management, School of Public Health, University of California, Berkeley, USA.
Jingshen WangDivision of Biostatistics, School of Public Health, University of California, Berkeley, CA, USA.
Amon Sabasaba *Health for a Prosperous Nation, Dar Es Salaam, Tanzania.
Sandra I McCoy *Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.

Funding

Strengthening the continuity of HIV care in Tanzania with economic supportR01MH125746 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI SABASABA, AMON NKWABI, WANG, JINGSHEN · 2021 to 2025
$3.3M
NIMH NIH HHS R01 MH125746
6 · The paper itself

Abstract

backgroundEconomic incentives can improve clinical outcomes among in-care people living with HIV (PLHIV), but evidence is limited for their effectiveness among out-of-care PLHIV or those at risk of disengagement. We propose a type 1 hybrid effectiveness-implementation study to advance global knowledge about the use of economic incentives to strengthen the continuity of HIV care and accelerate global goals for HIV epidemic control.

methodsThe Rudi Kundini, Pamoja Kundini study will evaluate two implementation models of an economic incentive strategy for supporting two groups of PLHIV in Tanzania. Phase 1 of the study consists of a two-arm, cluster randomized trial across 32 health facilities to assess the effectiveness of a home visit plus one-time economic incentive on the proportion of out-of-care PLHIV with viral load suppression (< 1000 copies/ml) 6 months after enrollment (n = 640). Phase 2 is an individual 1:1 randomized controlled trial designed to determine the effectiveness of a short-term counseling and economic incentive program offered to in-care PLHIV who are predicted through machine learning to be at risk of disengaging from care on the outcome of viral load suppression at 12 months (n = 692). The program includes up to three incentives conditional upon visit attendance coupled with adapted counselling sessions for this population of PLHIV. Consistent with a hybrid effectiveness-implementation study design, phase 3 is a mixed methods evaluation to explore barriers and facilitators to strategy implementation in phases 1 and 2. Results will be used to guide optimization and scale-up of the incentive strategies, if effective, to the larger population of Tanzanian PLHIV who struggle with continuity of HIV care. DISCUSSION: Innovative strategies that recognize the dynamic process of lifelong retention in HIV care are urgently needed. Strategies such as conditional economic incentives are a simple and effective method for improving many health outcomes, including those on the HIV continuum. If coupled with other supportive services such as home visits (phase 1) or with tailored counselling (phase 2), economic incentives have the potential to strengthen engagement among the subpopulation of PLHIV who struggle with retention in care and could help to close the gap towards reaching global "95-95-95" goals for ending the AIDS epidemic.

trial registrationPhase 1: ClinicalTrials.gov, NCT05248100 , registered 2/21/2022. Phase 2: ClinicalTrials.gov, NCT05373095 , registered 5/13/2022.

Indexed as

HIV InfectionsMotivationClinical Trials, Phase II as TopicContinuity of Patient CareData ScienceHumansRandomized Controlled Trials as TopicTanzaniaConditional cash transfersEconomic incentivesEffectiveness-implementation hybridHIV/AIDSTanzania

Identifiers

PMID38336793
PMCPMC10858527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.